Longitudinal Assessment of Preterm Infants Treated with Erythropoiesis Stimulating Agents.
Robin K OhlsJean LoweRonald A YeoShrena PatelSarah WinterRichard A CampbellShawna BakerJohn Phillips
Published in: Current pediatric reviews (2023)
ESA recipients had better outcomes than placebo recipients, and were similar to term children. ESAs may improve long-term cognition and executive function in preterm infants.